Website FeedbackFeedback   Print Print   Share Share

 

Learning Center

Articles


 

GI Effects

Bralley JA, Lord RS, David RM, "DNA Detection of Gut Microbiota", GIfx White Paper, 2007

Amino Acids

Bralley JA, and Lord RS, “Treatment of Chronic Fatigue Syndrome with Specific Amino Acid Supplementation. Journal of Applied Nutrition. 1994. 46(3): p. 74-78.

Bongiovanni B, and Feinerman J, “Amino Acid Profiling: Clinical Guidelines for Determination of Preferred Specimen Choice.” Townsend Letter for Doctors & Patients. 2003. 245: p. 38-42.

Bralley JA, Lord RS, David RM, Bongiovanni B, Asymmetric Dimethylarginine: A Modifiable Risk Factor for Cardiovascular Disease. Metametrix white paper (PDF) 2003.

Lord RS, and Fitzgerald K, Hypohomocysteinemia. Metametrix white paper, 2005.

Fatty Acids

Lord RS, and Bralley JA, “Polyunsaturated fatty acid-induced antioxidant insufficiency. Int Med. 2002. 1(1): p. 38-44.

The Fatty Acid Profile: Dietary Intake and Beyond (PDF) July 2006

Organic Acids

Neustadt J, “Mitochondrial Dysfunction and Disease.” Integrative Medicine. 2006 June/July 5(3): p.14-20.

Burdette, Cheryl K., “How to Assess Patient Biochemical and Nutritional Individuality through Organic Acid Testing.”  Townsend Letter for Doctors and Patients. 2006.

Lord RS, “Urinary Markers of Intestinal Yeast. Townsend Letter for Doctors. 2003. December (245): p. 96-97.

Lord RS, Burdette C, and Bralley JA, “Urinary Markers of Yeast Overgrowth. Integrative Medicine. 2004. 3(5): p. 24-29.

Lord RS, Burdette CK, and Bralley JA, “Significance of Urinary Tartaric Acid.” Clin Chem. 2005. 51(3): p. 672-3.

Lord RS, “Autistic therapies focused by laboratory data. Part I: Organic Acids. Nutrition Practitioner. 2005. 6(3): p. 1-7.

Porphyrins

Lord RS, and Bralley JA, "Urinary Porphyrin Profiling," excerpt from Laboratory Evaluations in Functional and Integrative Medicine, 2007.

Hormones / Cell Regulators

Lord RS, Bongiovanni B, and Bralley JA, “Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites.” Altern Med Rev. 2002. 7(2): p. 112-29.

Lord, Richard Burdette, Cheryl, Measuring Urinary Estrogen Metabolites for Cancer Risk Assessment Metametrix white paper (PDF) 2006.

General Clinical Laboratory

Lord RS, “Definitions of clinical laboratory reference limits. Townsend Letter for Doctors & Patients. 2004. 246: p. 81-85.

Vitamin D: A Clinical Perspective (pdf)

Nelson-Dooley C, Lord RS, Bralley JA, "Why Test for Coenzyme Q10?" Metametrix White Paper (PDF) 2006.

Neopterin and Biopterin - Metametrix White Paper (PDF) 2008.

 

Celebrating 25 Years of Service